TeraView, the pioneer and leader in terahertz technology and solutions is pleased to announce that the Company has been awarded two new patents in Korea and Taiwan, further enhancing the protection of TeraView’s unique intellectual property (IP) employed to test and inspect advanced 2.5D/3D semiconductor packaging. Advanced semiconductor packaging is used extensively in chips for […]
Settlement Supports Vizgen’s Continued Commercialization and Ongoing Development of Transformative MERFISH Technology CAMBRIDGE, Mass. — Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today released an open letter in response to the settlement of litigation between Vizgen, Harvard University and 10X Genomics in the United States District […]
Billerica, MA – Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the issuance of a new patent (US 12,222,279 B2) for its advanced flow-cell technology, reinforcing the company’s commitment to driving innovation in bioprocess analytics. This milestone expands Nirrin’s capabilities in real-time process monitoring, offering greater precision, flexibility, and efficiency […]
IRVINE, Calif. – Zymo Research Corporation acknowledges the recent ruling, on March 14, 2025, by the United States District Court for the Central District of California in the ongoing litigation with QIAGEN GmbH. The Court has denied QIAGEN’s Partial Motion to Dismiss and, in the alternative, to stay certain counterclaims brought by Zymo Research, including claims […]
Promega Corporation has filed a patent infringement lawsuit against Aobious, Inc. regarding a key component of NanoLuc® luciferase technology. The lawsuit aims to halt unauthorized sales of furimazine substrates by Aobious. Furimazine substrates are protected by multiple active patents held by Promega. Madison, WI USA. — Promega Corporation announced today that it has filed a […]
10x Genomics’ ATAC-Seq patents found valid and infringed PLEASANTON, Calif. — 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court for the District of Delaware, Parse agreed – […]
European Patent Office grants new CRISPR/Cas9 patent (EP 4 289 948) to CVC, with broad claims covering guide RNAs and their combination with Cas9. Patent strengthens CVC’s leading position in European CRISPR IP landscape, providing security to over 150 ERS Genomics licensees. DUBLIN, IRELAND and CHESHIRE, UK – ERS Genomics (‘ERS’), which was established to provide […]
WALTHAM, Mass. — Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to enforce Revvity’s rights under its agreements with Cloud Software Group (CSG) related to the Spotfire® software. This ruling follows a preliminary injunction issued in April 2024, which will become permanent, ensuring uninterrupted access […]
Seattle, WA – Pluristyx, the leading provider of innovative induced pluripotent stem cells (iPSC), announces the issuance of the groundbreaking induced Allogeneic Cell Tolerance (iACT Stealth™) U.S. Patent No. 12,178,835. This patent marks a significant milestone in Pluristyx’s mission to bring advanced cell therapy solutions to the global market. Additionally, patents for iACT Stealth™ have been issued or are […]
Decision Marks a Significant Legal Victory for Parse Biosciences, Reinforcing Commitment to Innovation and Fair Competition SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued Final Written Decisions invalidating […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
